BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28798290)

  • 1. Bradycardia and Hypothermia Complicating Azithromycin Treatment.
    Benn K; Salman S; Page-Sharp M; Davis TME; Buttery JP
    Am J Case Rep; 2017 Aug; 18():883-886. PubMed ID: 28798290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval prolongation and extreme bradycardia after a single dose of azithromycin.
    Santos N; Oliveira M; Galrinho A; Oliveira JA; Ferreira L; Ferreira R
    Rev Port Cardiol; 2010 Jan; 29(1):139-42. PubMed ID: 20391905
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothermia from azithromycin?
    Walson PD
    J Toxicol Clin Toxicol; 1997; 35(5):459. PubMed ID: 9279302
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delirium in the elderly resulting from azithromycin therapy.
    Cone LA; Padilla L; Potts BE
    Surg Neurol; 2003 Jun; 59(6):509-11. PubMed ID: 12826358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is azithromycin treatment associated with prolongation of the Q-Tc interval?
    Strle F; Maraspin V
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous azithromycin-induced ototoxicity.
    Bizjak ED; Haug MT; Schilz RJ; Sarodia BD; Dresing JM
    Pharmacotherapy; 1999 Feb; 19(2):245-8. PubMed ID: 10030778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of azithromycin after single- and multiple-doses in children.
    Stevens RC; Reed MD; Shenep JL; Baker DK; Foulds G; Luke DR; Blumer JL; Rodman JH
    Pharmacotherapy; 1997; 17(5):874-80. PubMed ID: 9324176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin-Induced Bradycardia.
    Abdelazeem B; Hollander RM; Ayad S; Gergis K; Gismalla ME
    Cureus; 2021 Aug; 13(8):e16995. PubMed ID: 34540397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.
    Pokharel S; Basnyat B; Arjyal A; Mahat SP; Kc RK; Bhuju A; Poudyal B; Kestelyn E; Shrestha R; Phuong DNT; Thapa R; Karki M; Dongol S; Karkey A; Wolbers M; Baker S; Thwaites G
    Trials; 2017 Oct; 18(1):450. PubMed ID: 28969659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
    Langley JM; Halperin SA; Boucher FD; Smith B;
    Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin-induced QT prolongation in elderly patient.
    Russo V; Puzio G; Siniscalchi N
    Acta Biomed; 2006 Apr; 77(1):30-2. PubMed ID: 16856707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of azithromycin in tonsilar and/or adenoid tissue from paediatric patients.
    Vaudaux BP; Cherpillod J; Dayer P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():45-51. PubMed ID: 8818845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-threatening bradyarrhythmia after massive azithromycin overdose.
    Tilelli JA; Smith KM; Pettignano R
    Pharmacotherapy; 2006 Jan; 26(1):147-50. PubMed ID: 16506357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated International Normalized Ratio associated with long-term azithromycin therapy in a child with cerebral palsy.
    Stork CM; Marraffa JM; Ragosta K; Wojcik SM; Angelino KL
    Am J Health Syst Pharm; 2011 Jun; 68(11):1012-4. PubMed ID: 21593229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.